Benzodiazepines Deprescribing in Nursing Homes: Intervention Feasibility

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-22

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting.

The main questions it aims to answer are:

* Is the intervention we developped feasible
* To what extent will the intervention be implemented in nursing homes
* To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants

Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work.

Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID)

NCT06173154

Aged

COMPLETED NA

An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults

NCT01148186

Polypharmacy Incontinence Insomnia +1 more

TERMINATED PHASE4

Non Pharmacological Management of Behavioural Symptoms in Nursing Home

NCT00824967

ALZHEIMER Disease

TERMINATED NA

Reducing Inappropriate Benzodiazepine Use Among Older Adults

NCT03405298

Long Term Use of Benzodiazepine

COMPLETED NA

De-prescribing Program to Evaluate Falls in Older Adults

NCT04272671

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benzodiazepines Deprescribing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

END-IT intervention for nursing homes

This complex intervention, implemented at the level of the nursing home, encompasses process and goals setting, education for healthcare providers, environmental adaptations, audit and feedback on benzodiazepine use, use of an educational leaflet for residents and relatives, and multidisciplinary work.

Group Type EXPERIMENTAL

END-IT intervention for nursing homes

Intervention Type OTHER

Complex intervention, as described in the arm/group descriptions

Control

Usual care. Nursing homes allocated to this study arm will access intervention material at the end of the study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

END-IT intervention for nursing homes

Complex intervention, as described in the arm/group descriptions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65 years old and older
* Taking at least one benzodiazepine or Z-drug for 4 weeks or more

Exclusion Criteria

* Unability to communicate in French
* Palliative care
* Ongoing benzodiazepine withdrawal
* Ongoing alcohol withdrawal
* Severe anxiety
* Severe depression

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No